272 related articles for article (PubMed ID: 21519360)
1. Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study.
Vakil NB; Huff FJ; Bian A; Jones DS; Stamler D
Am J Gastroenterol; 2011 Aug; 106(8):1427-38. PubMed ID: 21519360
[TBL] [Abstract][Full Text] [Related]
2. Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease--insights into study design for transient lower sphincter relaxation inhibitors.
Vakil NB; Huff FJ; Cundy KC
Aliment Pharmacol Ther; 2013 Jul; 38(2):107-17. PubMed ID: 23721547
[TBL] [Abstract][Full Text] [Related]
3. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease.
Gerson LB; Huff FJ; Hila A; Hirota WK; Reilley S; Agrawal A; Lal R; Luo W; Castell D
Am J Gastroenterol; 2010 Jun; 105(6):1266-75. PubMed ID: 20040914
[TBL] [Abstract][Full Text] [Related]
4. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
Kahrilas PJ; Howden CW; Hughes N
Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injury.
Nance PW; Huff FJ; Martinez-Arizala A; Ayyoub Z; Chen D; Bian A; Stamler D
Spinal Cord; 2011 Sep; 49(9):974-80. PubMed ID: 21577221
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
[TBL] [Abstract][Full Text] [Related]
7. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
[TBL] [Abstract][Full Text] [Related]
8. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.
Miner P; Orr W; Filippone J; Jokubaitis L; Sloan S
Am J Gastroenterol; 2002 Jun; 97(6):1332-9. PubMed ID: 12094846
[TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.
Spechler SJ; Hunter JG; Jones KM; Lee R; Smith BR; Mashimo H; Sanchez VM; Dunbar KB; Pham TH; Murthy UK; Kim T; Jackson CS; Wallen JM; von Rosenvinge EC; Pearl JP; Laine L; Kim AW; Kaz AM; Tatum RP; Gellad ZF; Lagoo-Deenadayalan S; Rubenstein JH; Ghaferi AA; Lo WK; Fernando RS; Chan BS; Paski SC; Provenzale D; Castell DO; Lieberman D; Souza RF; Chey WD; Warren SR; Davis-Karim A; Melton SD; Genta RM; Serpi T; Biswas K; Huang GD
N Engl J Med; 2019 Oct; 381(16):1513-1523. PubMed ID: 31618539
[TBL] [Abstract][Full Text] [Related]
10. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
11. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
12. IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial.
Vaezi MF; Fass R; Vakil N; Reasner DS; Mittleman RS; Hall M; Shao JZ; Chen Y; Lane L; Gates AM; Currie MG
Gastroenterology; 2020 Jun; 158(8):2093-2103. PubMed ID: 32092310
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
[TBL] [Abstract][Full Text] [Related]
14. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial.
Shaheen NJ; Denison H; Björck K; Karlsson M; Silberg DG
Gut; 2013 Sep; 62(9):1248-55. PubMed ID: 22730470
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD.
Winter H; Kum-Nji P; Mahomedy SH; Kierkus J; Hinz M; Li H; Maguire MK; Comer GM
J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):609-18. PubMed ID: 20400912
[TBL] [Abstract][Full Text] [Related]
18. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms.
Scarpellini E; Boecxstaens V; Broers C; Vos R; Pauwels A; Tack J
Dis Esophagus; 2016 Nov; 29(8):1054-1063. PubMed ID: 26541138
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease.
Fass R; Chey WD; Zakko SF; Andhivarothai N; Palmer RN; Perez MC; Atkinson SN
Aliment Pharmacol Ther; 2009 Jun; 29(12):1261-72. PubMed ID: 19392864
[TBL] [Abstract][Full Text] [Related]
20. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
